Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ethics
•
Psychiatry
•
General Outpatient Psychiatry
•
ADHD
How do you respond to early refill requests for stimulants in stable patients who report lost or stolen medication?
How do you balance preserving the therapeutic alliance with ensuring appropriate risk mitigation?
Related Questions
When do you use SNRIs or norepinephrine reuptake inhibitors (e.g., atomoxetine) for the treatment of ADHD?
When and how do you approach prescribing viloxazine for patients with ADHD?
How do you approach requests for academic accommodations such as extended test time in college students with ADHD?
How do you navigate C-2 refills in patients who are stable in their treatment and do not otherwise need to be clinically seen monthly?
How do you approach stimulant prescribing for ADHD when a patient has previously reported palpitations with stimulants but has a normal EKG off medication?
How do you approach a treatment relationship with a patient who is non-adherent to recommendations and also is not interested in transfer to another practitioner?
What medications do you recommend for a patient with ADHD and anxiety who becomes more anxious on a stimulant?
How do you approach firearm safety counseling for outpatients with elevated suicide risk who do not meet criteria for involuntary psychiatric hospitalization?
What are your concerns regarding long term stimulant use in geriatric patients with ADHD?
When would you consider transdermal treatments for ADHD?